Virocell Biologics Ltd
Biotechnology company · London, England, United Kingdom
Virocell Biologics Ltd is a biotechnology company headquartered in London, England, United Kingdom. Its earliest recorded incorporation is in 2020. It has reported private securities offerings to the US SEC, most recently $992,645 sold in a notice filed in 2022.
Virocell Biologics at a glance
What does Virocell Biologics do?
Private fundraising reported to the SEC
1 Form D notice; the most recent reported $992,645 sold (2022).
Frequently asked questions about Virocell Biologics
Where is Virocell Biologics headquartered?
Virocell Biologics Ltd is headquartered in London, England, United Kingdom.
What does Virocell Biologics do?
Virocell Biologics Ltd is a biotechnology company.
When was Virocell Biologics founded?
The earliest incorporation on record for Virocell Biologics Ltd is in 2020, according to public company registers.
Similar companies
- Orchard Therapeutics plcLondon, England, United Kingdom
- Gyroscope Therapeutics LtdLondon, England, United Kingdom
- CHARM Therapeutics Inc.London, England, United Kingdom
- Duke Street Bio LtdLondon, England, United Kingdom
- Autolus Therapeutics plcLondon, England, United Kingdom
- Oppilan Pharma LtdLondon, England, United Kingdom
- OKYO Pharma LtdLondon, England, United Kingdom
- Beacon Therapeutics LimitedLondon, England, United Kingdom
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-23. Data licences